Ongoing research in this field aims to develop interventions targeting NRF2-KEAP1 epigenetic modifications that can be reversible or inherited during cell division, with the potential for chemoprevention, overcoming resistance and improving prognosis for NSCLC patients [79]. This evidence concerns the gene KEAP1 and non-small cell lung carcinoma.